Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 22 03:54PM ET
12.97
Dollar change
+0.67
Percentage change
5.45
%
IndexRUT P/E- EPS (ttm)-3.04 Insider Own64.61% Shs Outstand47.67M Perf Week-6.76%
Market Cap644.61M Forward P/E- EPS next Y-3.43 Insider Trans-0.44% Shs Float17.59M Perf Month-18.27%
Income-123.57M PEG- EPS next Q-0.81 Inst Own28.94% Short Float2.55% Perf Quarter-14.78%
Sales0.00M P/S- EPS this Y3.21% Inst Trans-0.53% Short Ratio3.00 Perf Half Y25.01%
Book/sh5.57 P/B2.33 EPS next Y-16.48% ROA-37.35% Short Interest0.45M Perf Year-6.49%
Cash/sh6.11 P/C2.12 EPS next 5Y- ROE-46.39% 52W Range9.94 - 20.22 Perf YTD-19.19%
Dividend Est.- P/FCF- EPS past 5Y-241.80% ROI-39.40% 52W High-35.86% Beta0.87
Dividend TTM- Quick Ratio10.62 Sales past 5Y0.00% Gross Margin- 52W Low30.48% ATR (14)0.92
Dividend Ex-Date- Current Ratio10.62 EPS Y/Y TTM40.14% Oper. Margin0.00% RSI (14)37.62 Volatility7.49% 6.48%
Employees90 Debt/Eq0.19 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price29.25
Option/ShortNo / Yes LT Debt/Eq0.18 EPS Q/Q-38.12% Payout- Rel Volume0.38 Prev Close12.30
Sales Surprise- EPS Surprise4.88% Sales Q/Q- EarningsMar 20 AMC Avg Volume149.16K Price12.97
SMA20-11.51% SMA50-18.91% SMA200-9.88% Trades Volume55,524 Change5.45%
Date Action Analyst Rating Change Price Target Change
Dec-13-23Initiated H.C. Wainwright Buy $28
Apr-14-24 12:52PM
Apr-06-24 01:33AM
Mar-21-24 02:32AM
Mar-20-24 09:53PM
04:00PM
11:55PM Loading…
Mar-08-24 11:55PM
Feb-22-24 11:27PM
Feb-05-24 04:05PM
Jan-18-24 07:00AM
Jan-08-24 07:00AM
Jan-03-24 06:28PM
Dec-19-23 01:01PM
Dec-05-23 09:48PM
Nov-30-23 09:55AM
Nov-21-23 11:03AM
12:00PM Loading…
Nov-14-23 12:00PM
09:55AM
Nov-09-23 04:05PM
Nov-01-23 04:48PM
Sep-26-23 04:01PM
Sep-25-23 07:00AM
Sep-19-23 08:05PM
04:09PM
Aug-24-23 10:40AM
Aug-14-23 05:08PM
07:00AM
Jun-07-23 09:55AM
May-22-23 09:55AM
May-12-23 04:05PM
May-09-23 07:00AM
06:45AM Loading…
Apr-25-23 06:45AM
HilleVax, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel vaccines. Its pipeline includes Norovirus and HIL-214. The company was founded by Maurice Hilleman and Tadataka Yamada on March 25, 2020 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kohli AdityaDirectorApr 05 '24Sale14.446,00086,640789,776Apr 05 05:48 PM
Frazier Life Sciences X, L.P.10% OwnerApr 04 '24Buy14.508,850128,3258,544,187Apr 08 04:22 PM
Kohli AdityaDirectorApr 04 '24Sale14.716,00088,245795,776Apr 05 05:48 PM
Kohli AdityaDirectorApr 03 '24Sale14.936,00089,582801,776Apr 05 05:48 PM
McLoughlin SeanChief Operating OfficerMar 28 '24Buy16.981,25021,2251,250Apr 01 04:08 PM
Kohli AdityaDirectorMar 20 '24Sale16.426,00098,533807,776Mar 20 06:27 PM
Kohli AdityaDirectorMar 19 '24Sale17.426,000104,492813,776Mar 20 06:27 PM
Kohli AdityaDirectorMar 18 '24Sale17.666,000105,937819,776Mar 20 06:27 PM
Kohli AdityaDirectorMar 08 '24Sale18.666,000111,959825,776Mar 08 06:38 PM
Kohli AdityaDirectorMar 07 '24Sale18.376,000110,213831,776Mar 08 06:38 PM
Kohli AdityaDirectorMar 06 '24Sale18.956,000113,701837,776Mar 08 06:38 PM
Kohli AdityaDirectorFeb 22 '24Sale15.056,00090,312843,776Feb 22 05:20 PM
Kohli AdityaDirectorFeb 21 '24Sale14.926,00089,495849,776Feb 22 05:20 PM
Kohli AdityaDirectorFeb 20 '24Sale14.886,00089,272855,776Feb 22 05:20 PM
Kohli AdityaDirectorFeb 12 '24Sale15.326,00091,921861,776Feb 14 04:22 PM
HERSHBERG ROBERTSee RemarksFeb 08 '24Sale14.9311,597173,161953,831Feb 12 07:47 PM
Kohli AdityaDirectorFeb 08 '24Sale14.938,866132,383812,878Feb 12 08:06 PM
Borkowski AstridChief Medical OfficerFeb 08 '24Sale14.933,93358,726161,260Feb 12 07:35 PM
Maltbie ShaneChief Financial OfficerFeb 08 '24Sale14.933,57653,39540,656Feb 12 07:51 PM
Borkowski AstridChief Medical OfficerDec 15 '23Sale15.5010,000155,000165,193Dec 18 05:34 PM
Borkowski AstridChief Medical OfficerDec 04 '23Sale14.5010,000145,000175,193Dec 05 04:52 PM
Borkowski AstridChief Medical OfficerDec 01 '23Sale14.2010,000142,000185,193Dec 05 04:52 PM
Borkowski AstridChief Medical OfficerNov 17 '23Sale14.0010,000140,000195,193Nov 20 04:53 PM
Borkowski AstridChief Medical OfficerNov 08 '23Sale13.005,00065,000205,193Nov 13 05:25 PM